| Rivercross Hospice 9920 East 42nd Street, Suite 201, Tulsa, OK, 74146 | |
| (918) 622-9281 |
News Archive
Scientists at the University of Pennsylvania School of Medicine have developed a new model of skin cancer based on the knowledge that a common cancer-related molecule called Src kinase is activated in human skin-cancer samples.
Two major international studies looking at data from a quarter of a million people around the globe have found a new set of genes associated with body fat distribution and obesity. Researchers at 280 institutions worldwide, including Albert Einstein College of Medicine of Yeshiva University, conducted the studies. The research, published in the October 10 online edition of Nature Genetics, sheds light on the biological processes involved in body fat distribution, possibly leading to new ways of treating obesity.
Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear today in the online issue of Journal of Clinical Oncology.
The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc. notes the finding of the Patents Court of the High Court of Justice of England and Wales in the patent litigation brought by Kinetic Concepts, Inc.. In that case, the Court found that parts of the Smith & Nephew RENASYS™ EZ and RENASYS GO Negative Pressure Wound Therapy (NPWT) Systems have infringed the patents EP0853950 and EP0777504 in the United Kingdom. Today the Court has given Smith & Nephew the right to Appeal this decision. Our full range of RENASYS products remains on the market."
iCardiac Technologies, a market and scientific leader in the conduct of cardiac safety assessments, announced today that it has launched the industry's first full risk-sharing program for Thorough QT studies. Leveraging its innovative High Precision QT™ methodology for analyzing ECG waveforms, iCardiac's program guarantees to sponsors that one of two desirable outcomes will be achieved.
› Verified 1 days ago
| Name | Rivercross Hospice |
|---|---|
| Location | 9920 East 42nd Street, Suite 201, Tulsa, Oklahoma |
| Hospice ID | 371683 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 710 |
News Archive
Scientists at the University of Pennsylvania School of Medicine have developed a new model of skin cancer based on the knowledge that a common cancer-related molecule called Src kinase is activated in human skin-cancer samples.
Two major international studies looking at data from a quarter of a million people around the globe have found a new set of genes associated with body fat distribution and obesity. Researchers at 280 institutions worldwide, including Albert Einstein College of Medicine of Yeshiva University, conducted the studies. The research, published in the October 10 online edition of Nature Genetics, sheds light on the biological processes involved in body fat distribution, possibly leading to new ways of treating obesity.
Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear today in the online issue of Journal of Clinical Oncology.
The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc. notes the finding of the Patents Court of the High Court of Justice of England and Wales in the patent litigation brought by Kinetic Concepts, Inc.. In that case, the Court found that parts of the Smith & Nephew RENASYS™ EZ and RENASYS GO Negative Pressure Wound Therapy (NPWT) Systems have infringed the patents EP0853950 and EP0777504 in the United Kingdom. Today the Court has given Smith & Nephew the right to Appeal this decision. Our full range of RENASYS products remains on the market."
iCardiac Technologies, a market and scientific leader in the conduct of cardiac safety assessments, announced today that it has launched the industry's first full risk-sharing program for Thorough QT studies. Leveraging its innovative High Precision QT™ methodology for analyzing ECG waveforms, iCardiac's program guarantees to sponsors that one of two desirable outcomes will be achieved.
› Verified 1 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 79.7 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 27.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 95.2 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 66.7 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 97.1 | 97.3 |
| Patients who got timely treatment for shortness of breath | 93.7 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 87.2 | 93.3 |
News Archive
Scientists at the University of Pennsylvania School of Medicine have developed a new model of skin cancer based on the knowledge that a common cancer-related molecule called Src kinase is activated in human skin-cancer samples.
Two major international studies looking at data from a quarter of a million people around the globe have found a new set of genes associated with body fat distribution and obesity. Researchers at 280 institutions worldwide, including Albert Einstein College of Medicine of Yeshiva University, conducted the studies. The research, published in the October 10 online edition of Nature Genetics, sheds light on the biological processes involved in body fat distribution, possibly leading to new ways of treating obesity.
Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear today in the online issue of Journal of Clinical Oncology.
The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc. notes the finding of the Patents Court of the High Court of Justice of England and Wales in the patent litigation brought by Kinetic Concepts, Inc.. In that case, the Court found that parts of the Smith & Nephew RENASYS™ EZ and RENASYS GO Negative Pressure Wound Therapy (NPWT) Systems have infringed the patents EP0853950 and EP0777504 in the United Kingdom. Today the Court has given Smith & Nephew the right to Appeal this decision. Our full range of RENASYS products remains on the market."
iCardiac Technologies, a market and scientific leader in the conduct of cardiac safety assessments, announced today that it has launched the industry's first full risk-sharing program for Thorough QT studies. Leveraging its innovative High Precision QT™ methodology for analyzing ECG waveforms, iCardiac's program guarantees to sponsors that one of two desirable outcomes will be achieved.
› Verified 1 days ago
| Home Health Aides | 6 |
| Counselors | 3 |
| Licensed Practical or Vocational Nurses | 7 |
| Medical Social Workers | 2 |
| Registered Nurses | 9 |
| Total Employees | 27 |
|---|
News Archive
Scientists at the University of Pennsylvania School of Medicine have developed a new model of skin cancer based on the knowledge that a common cancer-related molecule called Src kinase is activated in human skin-cancer samples.
Two major international studies looking at data from a quarter of a million people around the globe have found a new set of genes associated with body fat distribution and obesity. Researchers at 280 institutions worldwide, including Albert Einstein College of Medicine of Yeshiva University, conducted the studies. The research, published in the October 10 online edition of Nature Genetics, sheds light on the biological processes involved in body fat distribution, possibly leading to new ways of treating obesity.
Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear today in the online issue of Journal of Clinical Oncology.
The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc. notes the finding of the Patents Court of the High Court of Justice of England and Wales in the patent litigation brought by Kinetic Concepts, Inc.. In that case, the Court found that parts of the Smith & Nephew RENASYS™ EZ and RENASYS GO Negative Pressure Wound Therapy (NPWT) Systems have infringed the patents EP0853950 and EP0777504 in the United Kingdom. Today the Court has given Smith & Nephew the right to Appeal this decision. Our full range of RENASYS products remains on the market."
iCardiac Technologies, a market and scientific leader in the conduct of cardiac safety assessments, announced today that it has launched the industry's first full risk-sharing program for Thorough QT studies. Leveraging its innovative High Precision QT™ methodology for analyzing ECG waveforms, iCardiac's program guarantees to sponsors that one of two desirable outcomes will be achieved.
› Verified 1 days ago
| Others | 18 |
| Total Volunteers | 18 |
|---|
News Archive
Scientists at the University of Pennsylvania School of Medicine have developed a new model of skin cancer based on the knowledge that a common cancer-related molecule called Src kinase is activated in human skin-cancer samples.
Two major international studies looking at data from a quarter of a million people around the globe have found a new set of genes associated with body fat distribution and obesity. Researchers at 280 institutions worldwide, including Albert Einstein College of Medicine of Yeshiva University, conducted the studies. The research, published in the October 10 online edition of Nature Genetics, sheds light on the biological processes involved in body fat distribution, possibly leading to new ways of treating obesity.
Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear today in the online issue of Journal of Clinical Oncology.
The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc. notes the finding of the Patents Court of the High Court of Justice of England and Wales in the patent litigation brought by Kinetic Concepts, Inc.. In that case, the Court found that parts of the Smith & Nephew RENASYS™ EZ and RENASYS GO Negative Pressure Wound Therapy (NPWT) Systems have infringed the patents EP0853950 and EP0777504 in the United Kingdom. Today the Court has given Smith & Nephew the right to Appeal this decision. Our full range of RENASYS products remains on the market."
iCardiac Technologies, a market and scientific leader in the conduct of cardiac safety assessments, announced today that it has launched the industry's first full risk-sharing program for Thorough QT studies. Leveraging its innovative High Precision QT™ methodology for analyzing ECG waveforms, iCardiac's program guarantees to sponsors that one of two desirable outcomes will be achieved.
› Verified 1 days ago
| Saint Francis Hospice Location: 6600 South Yale, Suite 350, Tulsa, Oklahoma, 74136 Phone: (918) 622-9281 |
| Hospice Of Green Country, Inc Location: 1120 South Boston Ave,, Tulsa, Oklahoma, 74119 Phone: (918) 622-9281 |
| St John Hospice Location: 4720 S Harvard, Ste 202, Tulsa, Oklahoma, 74135 Phone: (918) 622-9281 |
| Seasons Hospice, Inc Location: 6532 E 71st Street #101, Tulsa, Oklahoma, 74133 Phone: (918) 622-9281 |